Tyra Biosciences (TYRA) Interest Expenses (2020 - 2023)
Tyra Biosciences (TYRA) reported Interest Expenses of $21000.0 for Q2 2023, up 61.54% on a YoY basis from $13000.0 in Q2 2022, and up 2000.0% quarter-over-quarter from $1000.0 in Q1 2023.
Tyra Biosciences (TYRA) Interest Expenses (2020 - 2023) Analysis & Trends
Tyra Biosciences has reported Interest Expenses for 4 years, with the latest figure at $21000.0 in Q2 2023.
- For the quarter ending Q2 2023, Interest Expenses rose 61.54% year-over-year to $21000.0; the trailing twelve-month figure through Mar 2024 stood at $21000.0 (down 59.62% YoY), and the FY2023 full-year result was $39000.0, down 22.0% from the prior year.
- Interest Expenses for Q2 2023 stood at $21000.0, up from $1000.0 in the prior quarter.
- The five-year high for Interest Expenses was $33000.0 in Q4 2022, with the low at $1000.0 in Q1 2023.
- Historically, Interest Expenses has averaged $10363.6 across 4 years, with a median of $7000.0 in 2020.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 1000.0% — and 2023, when it plunged 90.0%.
- Tyra Biosciences' Interest Expenses stood at $6000.0 in 2020, then slumped by 50.0% to $3000.0 in 2021, then jumped by 1000.0% to $33000.0 in 2022, then sank by 36.36% to $21000.0 in 2023.
- The last three Interest Expenses figures came in at $21000.0 (Q2 2023), $1000.0 (Q1 2023), and $33000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -5.58 Mn |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |